What is the current Neurointerventional Devices market size?

The Neurointerventional Devices market size is approximately USD 2.5 billion as of 2023.

What is the expected growth forecast for the Neurointerventional Devices market?

The market is expected to grow at a CAGR of 6.2% from 2023 to 2028, driven by increasing demand.

What are the key drivers of the Neurointerventional Devices market?

Key drivers include rising stroke incidence, technological advancements, and growing awareness of neurointerventional procedures.

What are the major challenges facing the Neurointerventional Devices market?

Challenges include high device costs, stringent regulatory requirements, and limited reimbursement options.

Which regions are leading the Neurointerventional Devices market?

North America and Europe are currently leading the market, due to high healthcare expenditure and adoption rates.

Who are the top companies in the Neurointerventional Devices market?

Top companies include Medtronic, Stryker, and Boston Scientific, which offer a wide range of neurointerventional devices.

What future opportunities exist in the Neurointerventional Devices market?

Future opportunities include emerging markets, innovative technologies, and increasing demand for minimally invasive procedures.

How is technology impacting the Neurointerventional Devices market?

Technological advancements, such as robotic-assisted procedures, are improving treatment outcomes and driving market growth.

What is the current regulatory landscape for Neurointerventional Devices?

The regulatory landscape is evolving, with increasing focus on device safety, efficacy, and post-market surveillance.

What is the future outlook for the Neurointerventional Devices market?

The future outlook is positive, with growing demand, innovative technologies, and expanding applications driving market growth.

How Big Is the Neurointerventional Devices Market? Size, Share & Forecast 2033

Neurointerventional Devices by Application (Hospitals, Ambulatory Surgical Centers), by Types (Embolic Coils, Neurovascular Stents (Carotid and Intracranial Stents), Intrasaccular Devices, Neurothrombectomy Devices, Flow Diverters, Embolic Protection Devices, Liquid Embolics, Balloons, Stent Retrievers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1680 million

CAGR: 7.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1680 million

CAGR: 7.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Neurointerventional Devices Market Overview

The Neurointerventional Devices market refers to the industry that provides medical devices used to treat neurological disorders and conditions. The Neurointerventional Devices market size is estimated to be around $2.5 billion in 2025. As the market is poised for significant growth, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is driven by the increasing prevalence of neurological disorders, advancements in technology, and the growing demand for minimally invasive procedures. The scope of the market includes devices such as neurovascular stents, embolic coils, and neurothrombectomy devices.

Loading chart…

The Neurointerventional Devices market is expected to grow at a CAGR of around 8% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of neurological disorders, advancements in technology, and the growing demand for minimally invasive procedures. Key forces shaping the industry include technology shifts such as the development of new materials and designs, regulations such as the FDA's approval process, and competitive intensity among market players. The largest region for the Neurointerventional Devices market is North America, while the fastest-growing region is expected to be Asia-Pacific. The market is highly competitive, with major players such as Medtronic, Stryker, and Boston Scientific competing for market share.

Report Overview

Report Attribute	Details
Market size value in 2025	1.68 billion
Revenue forecast in 2033	2.93 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Penumbra; Stryker; Terumo; Johnson & Johnson; Abbott; Synapse Biomedical; Aesculap; Boston Scientific; BrainLab; Elekta; Karl Storz; Micromar
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Neurointerventional Devices market is poised for significant growth, driven by factors such as advancements in technology and an increasing demand for minimally invasive procedures. As the Neurointerventional Devices market size continues to expand, it is essential to understand the dynamics that will shape its future.

Growth Drivers2 items

Advancements in technology, such as the development of more precise and minimally invasive devices, are driving growth in the Neurointerventional Devices market, enabling better treatment outcomes and improving patient care

The increasing prevalence of neurological disorders, such as stroke and aneurysms, is fueling demand for Neurointerventional Devices, with the growth forecast indicating a significant rise in the market size over the next few years

Restraints2 items

Stringent regulatory requirements and high development costs are restraining the growth of the Neurointerventional Devices market, as companies must navigate complex approval processes and invest heavily in research and development

The lack of skilled professionals and training programs is also limiting the adoption of Neurointerventional Devices, particularly in emerging markets where healthcare infrastructure and resources may be limited

Opportunities2 items

The increasing demand for minimally invasive procedures and the growing awareness of Neurointerventional Devices among patients and healthcare professionals are creating opportunities for market players to develop innovative products and solutions

The expansion of healthcare infrastructure in developing countries is also providing opportunities for Neurointerventional Devices market players to tap into new markets and customer bases, driving growth and revenue

Challenges2 items

The high cost of Neurointerventional Devices and procedures is a significant challenge, as it can limit access to these life-saving technologies, particularly in low-income countries where healthcare budgets are constrained

The management of complex supply chains and the maintenance of product quality are also key challenges facing Neurointerventional Devices market players, as they must balance the need for innovation with the need for reliability and safety

Market Segmentation

Loading chart…

The Neurointerventional Devices market can be segmented based on Application, which refers to the specific therapeutic areas where these devices are used. This segmentation is critical in understanding the Neurointerventional Devices segmentation landscape, as different applications have varying demands and growth prospects. The main applications include ischemic stroke, hemorrhagic stroke, and cerebral arteriovenous malformations (AVMs), among others. Each application contributes to the overall Neurointerventional Devices market size, with ischemic stroke treatment being the largest segment due to the high prevalence of this condition.

Another key segmentation category in the Neurointerventional Devices market is Types, which encompasses various subtypes such as embolization devices, angioplasty devices, thrombectomy devices, and aneurysm coiling devices. These subtypes are crucial in market taxonomy as they cater to different needs within the neurointerventional space. Embolization devices, for instance, are used to treat conditions like AVMs and aneurysms by blocking blood flow, while thrombectomy devices are specifically designed for removing blood clots in acute ischemic stroke patients. Understanding these types and their subcategories is essential for analyzing the market's dynamics and potential.

Neurointerventional Devices Segmentation Breakdown13 items

Application

Hospitals

Ambulatory Surgical Centers

Types

Embolic Coils

Neurovascular Stents (Carotid and Intracranial Stents)

Intrasaccular Devices

Neurothrombectomy Devices

Flow Diverters

Embolic Protection Devices

Liquid Embolics

Balloons

Stent Retrievers

Regional Insights

Loading chart…

The Neurointerventional Devices market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of neurointerventional devices, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics with an aging population, infrastructure with well-established healthcare systems, and ecosystem maturity with a high level of awareness about neurointerventional devices. For Europe, factors such as regional forecast indicating steady growth, policies supporting medical device innovation, and adoption of advanced technologies are crucial. In Asia Pacific, investments in healthcare, demographics with a large and growing population, and infrastructure development are key. Latin America's growth is driven by adoption of neurointerventional devices, policies aimed at improving healthcare access, and ecosystem maturity. The Middle East & Africa region is influenced by investments in healthcare infrastructure, demographics with a growing population, and policies supporting medical tourism.

Competitive Landscape

The Neurointerventional Devices market exhibits a moderately consolidated structure, with a mix of global players and local companies competing for market share. The Neurointerventional Devices competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies rely on competitive pricing and strong distribution networks.

Companies in the Neurointerventional Devices market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. Common strategies among key players include expanding their product portfolios, strengthening their channel presence, and investing in localization efforts. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks, which can impact their competitive positioning. Key players are focusing on technology advancements, service model innovation, and cost advantages to maintain their competitive edge.

Medtronic - regional expansion

Penumbra - innovation pipeline

Stryker - premium pricing

Terumo - OEM tie-ups

Johnson & Johnson - local manufacturing

Abbott - vertical integration

Key Neurointerventional Devices Companies13 items

Medtronic

Penumbra

Stryker

Terumo

Johnson & Johnson

Abbott

Synapse Biomedical

Aesculap

Boston Scientific

BrainLab

Elekta

Karl Storz

Micromar

Market Ecosystem

The Neurointerventional Devices ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of these devices, ultimately reaching hospitals, clinics, and other healthcare facilities where they are used to treat neurological conditions. Understanding the Neurointerventional Devices ecosystem requires a value chain analysis to identify key participants, their roles, and interactions.

Raw material/component suppliers — providing critical device components

OEMs / manufacturers — designing and producing neurointerventional devices

Technology providers — developing underlying technologies and software

System integrators / EPCs — integrating devices into larger medical systems

Distributors / channel partners — delivering devices to healthcare facilities

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing and enforcing device safety and efficacy standards

The flow of value through the Neurointerventional Devices ecosystem is influenced by various control points, including regulatory approvals, reimbursement policies, and market demand. Dependency risks, such as input constraints and standards compliance, can impact device development and availability. Switching costs, partnerships, and interoperability requirements also affect the ecosystem, as healthcare facilities consider device compatibility and vendor relationships when making purchasing decisions. Furthermore, regional differences in healthcare infrastructure, regulatory frameworks, and market conditions can shape the ecosystem in distinct ways, highlighting the need for a nuanced understanding of these factors to navigate the Neurointerventional Devices ecosystem effectively.

Recent Industry Insights

The Neurointerventional Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Vanderbilt University, have focused on advancing neurointerventional technologies. Additionally, mergers and acquisitions, like the acquisition of Revive Therapeutics by NeuroPace, have contributed to the growth of the industry. Furthermore, several product launches, including the introduction of micro-catheters and stent retrievers, have expanded treatment options for neurological disorders. Regulatory changes, such as the FDA's updated guidelines for neurointerventional devices, have also impacted the industry. These developments have been supported by funding rounds and expansions, demonstrating a shift in consumer and enterprise trends towards innovative neurointerventional solutions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Neurointerventional Devices market outlook. The market attractiveness is high, driven by the increasing prevalence of neurological disorders and advancements in medical technology. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios. The long-term outlook is promising, with the Neurointerventional Devices market expected to grow significantly over the next five years.

The innovation landscape is evolving, with a focus on developing minimally invasive and image-guided procedures. The demand-supply balance is stable, with manufacturers working to meet the growing demand for neurointerventional devices. However, key risk factors include regulatory challenges and reimbursement issues. Overall, the Neurointerventional Devices market outlook is favorable, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Neurointerventional Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Neurointerventional Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Neurointerventional Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Ambulatory Surgical Centers

6.2. Global Neurointerventional Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Embolic Coils

6.2.2. Neurovascular Stents (Carotid and Intracranial Stents)

6.2.3. Intrasaccular Devices

6.2.4. Neurothrombectomy Devices

6.2.5. Flow Diverters

6.2.6. Embolic Protection Devices

6.2.7. Liquid Embolics

6.2.8. Balloons

6.2.9. Stent Retrievers

6.3. Global Neurointerventional Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Neurointerventional Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Neurointerventional Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Neurointerventional Devices Market Competition by Key Manufacturers

8.1. Global Neurointerventional Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Neurointerventional Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Penumbra

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Stryker

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Johnson & Johnson

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbott

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Synapse Biomedical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Aesculap

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Boston Scientific

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BrainLab

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Elekta

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Karl Storz

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Micromar

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Neurointerventional Devices Market

Figure 4: Global Neurointerventional Devices Market: Drivers

Figure 5: Global Neurointerventional Devices Market: Challenges

Figure 6: Global Neurointerventional Devices Market: Trends

Figure 7: Global Neurointerventional Devices Market: Opportunity

Figure 8: Global Neurointerventional Devices Market: Restraint

Figure 9: Global Neurointerventional Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Neurointerventional Devices Market Value (USD Million) By Region

Figure 15: Global Neurointerventional Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Neurointerventional Devices Market Value (USD Million) By Region

Figure 23: Global Neurointerventional Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Neurointerventional Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Neurointerventional Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Neurointerventional Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Neurointerventional Devices Market Value (USD Million) By Region

Table 10: Global Neurointerventional Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Neurointerventional Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Neurointerventional Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Neurointerventional Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Penumbra Basic Information And Sales Area

Table 33: Penumbra. Products Portfolio

Table 34: Stryker Basic Information And Sales Area

Table 35: Stryker. Products Portfolio

Table 36: Terumo Basic Information And Sales Area

Table 37: Terumo. Products Portfolio

Table 38: Johnson & Johnson Basic Information And Sales Area

Table 39: Johnson & Johnson. Products Portfolio

Table 40: Abbott Basic Information And Sales Area

Table 41: Abbott. Products Portfolio

Table 42: Synapse Biomedical Basic Information And Sales Area

Table 43: Synapse Biomedical. Products Portfolio

Table 44: Aesculap Basic Information And Sales Area

Table 45: Aesculap. Products Portfolio

Table 46: Boston Scientific Basic Information And Sales Area

Table 47: Boston Scientific. Products Portfolio

Table 48: BrainLab Basic Information And Sales Area

Table 49: BrainLab. Products Portfolio

Table 50: Elekta Basic Information And Sales Area

Table 51: Elekta. Products Portfolio

Table 52: Karl Storz Basic Information And Sales Area

Table 53: Karl Storz. Products Portfolio

Table 54: Micromar Basic Information And Sales Area

Table 55: Micromar. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Neurointerventional Devices Market Value (USD Million) By Region

Table 61: Global Neurointerventional Devices Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Neurointerventional Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.68 billion
Revenue forecast in 2033	2.93 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Penumbra; Stryker; Terumo; Johnson & Johnson; Abbott; Synapse Biomedical; Aesculap; Boston Scientific; BrainLab; Elekta; Karl Storz; Micromar
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Neurointerventional Devices Segmentation Breakdown13 items

Application

Hospitals

Ambulatory Surgical Centers

Types

Embolic Coils

Neurovascular Stents (Carotid and Intracranial Stents)

Intrasaccular Devices

Neurothrombectomy Devices

Flow Diverters

Embolic Protection Devices

Liquid Embolics

Balloons

Stent Retrievers

Regional Insights

Loading chart…

Competitive Landscape

Medtronic - regional expansion

Penumbra - innovation pipeline

Stryker - premium pricing

Terumo - OEM tie-ups

Johnson & Johnson - local manufacturing

Abbott - vertical integration

Key Neurointerventional Devices Companies13 items

Medtronic

Penumbra

Stryker

Terumo

Johnson & Johnson

Abbott

Synapse Biomedical

Aesculap

Boston Scientific

BrainLab

Elekta

Karl Storz

Micromar

Market Ecosystem

Raw material/component suppliers — providing critical device components

OEMs / manufacturers — designing and producing neurointerventional devices

Technology providers — developing underlying technologies and software

System integrators / EPCs — integrating devices into larger medical systems

Distributors / channel partners — delivering devices to healthcare facilities

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing and enforcing device safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents